Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Oral immunomodulatory drug for myeloma; strict pregnancy-prevention programme. | Proteasome inhibitor injection for multiple myeloma. |
| Body system | Cancer | Cancer |
| Drug class | Myeloma agents | Myeloma agents |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Multiple myeloma, Myelodysplastic syndromes with 5q deletion, Some lymphomas | Multiple myeloma, Mantle cell lymphoma |
| How it works | Boosts immune attack on myeloma cells. | Disrupts protein recycling in myeloma cells. |
| Starts working | Depends on the cancer and regimen | Depends on the cancer and regimen |
| Half-life | About 3 hours | 40–193 hours |
| Typical adult dose | Dosed by your cancer team according to the treatment protocol. | Dosed by your cancer team according to the treatment protocol. |
| Forms | Capsule | Subcutaneous injection, IV injection |
| Common side effects | Tiredness, Low blood counts, Diarrhoea, Constipation, Muscle cramps, Rash | Tingling and numbness, Low platelets, Nausea, Diarrhoea, Tiredness |
| Serious side effects | Blood clots, Severe neutropenia, Birth defects, Second cancers | Painful nerve damage, Low blood pressure, Shingles reactivation |
| Don't take if | Pregnancy; Women able to become pregnant without contraception; Severe kidney impairment without dose reduction | Pregnancy; Intrathecal administration (fatal) |
| Alcohol | Best to limit. Alcohol can add to tiredness. | Best to limit. Alcohol can worsen dizziness. |
| Pregnancy | Usually avoidedCauses severe birth defects. A pregnancy-prevention programme applies. | Usually avoidedAvoid. |
| Breastfeeding | Usually avoidedAvoid. | Usually avoidedAvoid. |
| In use since | — | — |
| Brand names | United States: RevlimidUnited Kingdom: RevlimidIndia: Revlimid, Lenalid, Lenalidomide (generic) | United States: VelcadeUnited Kingdom: VelcadeIndia: Velcade, Bortenat, Bortezomib (generic) |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H |
| ATC code | L04AX04 | L01XG01 |
Taken together
- ModerateLenalidomide + Bortezomib: Added bone marrow suppression
Both can lower white cells, red cells or platelets; together the risk of infection and bleeding rises.